Clinical trial

Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

NCT05806385

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2026-03-01Date precision: month

Registry last updated2025-09-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Cancerunresolved

Interventions

CryoablationDEVICE

Cryoablation combined with PD1 InhibitorCOMBINATION_PRODUCT

Sponsors & collaborators

Texas Tech University Health Sciences Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05806385 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.